1193 / 1196
Take Home Messages
•
Diligent
adverse event reporting should not be reserved for
clinical trials
•
Prospective
data collection that is electronic and easily
accessible
•
Language needs to be clear for
all
members of the team
accessing patient notes
•
Better equipped to assess impact of treatment in an evidence
based approach